CM Life Sciences II (OTCMKTS:CMIIU) Major Shareholder Buys $2,650,000.00 in Stock

CM Life Sciences II Inc. (OTCMKTS:CMIIU) major shareholder Circle 2 Sponsor Corp Columbus acquired 265,000 shares of the firm’s stock in a transaction on Thursday, February 12th. The shares were purchased at an average cost of $10.00 per share, for a total transaction of $2,650,000.00. Following the completion of the purchase, the insider directly owned 265,000 shares of the company’s stock, valued at approximately $2,650,000. The trade was a ∞ increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Major shareholders that own at least 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

CM Life Sciences II Price Performance

CM Life Sciences II stock traded down $0.01 on Tuesday, reaching $9.99. The company’s stock had a trading volume of 93,697 shares, compared to its average volume of 127,266. The business’s fifty day moving average price is $11.10 and its 200 day moving average price is $11.18. CM Life Sciences II Inc. has a twelve month low of $9.99 and a twelve month high of $10.02.

CM Life Sciences II Company Profile

CM Life Sciences II, Inc is a special purpose acquisition company (SPAC) incorporated in Delaware in February 2021. The company’s units trade on the OTC market under the ticker CMIIU. As a blank‐check company, CM Life Sciences II seeks to identify and acquire one or more businesses in the life sciences industry, including biotechnology, biopharmaceuticals, medical devices and related areas.

The company raised capital through its initial public offering in mid-2021, issuing public units each comprising one share of Class A common stock and a fraction of a warrant.